Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
作者信息
Chen Xiaoqing, Hu Yunwei, Su Wenru, Yang Shizhao, Wang Xiaoxiao, Zhang Ping, Hong Xiaoyu, Liang Chuqiao, Qian Zhuyun, Li Ziqiang, Tao Yong, Huang Huiqiang, Liang Dan
机构信息
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, P. R. China.
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
出版信息
Cancer Commun (Lond). 2022 Nov;42(11):1217-1221. doi: 10.1002/cac2.12344. Epub 2022 Aug 3.
Abstract
摘要
相似文献
1
Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Cancer Commun (Lond). 2022 Nov;42(11):1217-1221. doi: 10.1002/cac2.12344. Epub 2022 Aug 3.
2
Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma.
J Vis Exp. 2024 Jan 12(203). doi: 10.3791/65708.
3
Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
JAMA Ophthalmol. 2018 Oct 1;136(10):1098-1104. doi: 10.1001/jamaophthalmol.2018.2887.
4
Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
Ophthalmol Retina. 2023 Feb;7(2):189-195. doi: 10.1016/j.oret.2022.08.005. Epub 2022 Aug 8.
5
Perivascular tumour balls in primary vitreoretinal lymphoma.
BMJ Case Rep. 2018 Dec 14;11(1):e228006. doi: 10.1136/bcr-2018-228006.
6
A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
Haematologica. 2022 Sep 1;107(9):2154-2162. doi: 10.3324/haematol.2021.279908.
7
CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Retina. 2021 Dec 1;41(12):2596-2604. doi: 10.1097/IAE.0000000000003241.
8
[Research progress in the diagnosis of primary vitreoretinal lymphoma].
Zhonghua Yan Ke Za Zhi. 2023 Nov 11;59(11):954-959. doi: 10.3760/cma.j.cn112142-20230717-00004.
9
The challenge in the diagnosis and management of vitreoretinal lymphoma.
Clin Exp Ophthalmol. 2023 Mar;51(2):107-109. doi: 10.1111/ceo.14209. Epub 2023 Feb 15.
10
Primary intraocular lymphoma: A review.
Semin Ophthalmol. 2006 Jul-Sep;21(3):125-33. doi: 10.1080/08820530500350498.
引用本文的文献
1
Molecular diagnosis of vitreoretinal lymphoma.
Taiwan J Ophthalmol. 2024 Dec 24;15(2):236-244. doi: 10.4103/tjo.TJO-D-24-00052. eCollection 2025 Apr-Jun.
2
Clinical guidelines for the diagnosis and treatment of vitreoretinal lymphoma in Chinese patients (2024).
Eye Vis (Lond). 2025 May 26;12(1):20. doi: 10.1186/s40662-025-00434-4.
3
Have we truly uncovered the key to primary vitreoretinal lymphoma's pathway to the central nervous system?
Haematologica. 2024 Dec 1;109(12):4148-4149. doi: 10.3324/haematol.2024.286056.
4
Global collaboration of eye research: -personal experience.
Int J Ophthalmol. 2024 Jun 18;17(6):985-990. doi: 10.18240/ijo.2024.06.01. eCollection 2024.
本文引用的文献
1
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y.
2
Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.
Prog Retin Eye Res. 2022 Sep;90:101053. doi: 10.1016/j.preteyeres.2022.101053. Epub 2022 Feb 21.
3
A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
Haematologica. 2022 Sep 1;107(9):2154-2162. doi: 10.3324/haematol.2021.279908.
4
MYD88 and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy.
Ther Adv Hematol. 2022 Jan 31;13:20406207211072839. doi: 10.1177/20406207211072839. eCollection 2022.
5
The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Blood Adv. 2022 Mar 8;6(5):1598-1607. doi: 10.1182/bloodadvances.2021004212.
6
Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Ophthalmology. 2021 Jul;128(7):1079-1090. doi: 10.1016/j.ophtha.2020.11.018. Epub 2020 Nov 20.
7
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
8
Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Oncotarget. 2017 Jan 31;8(5):7989-7998. doi: 10.18632/oncotarget.14008.
9
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
Sci Transl Med. 2016 Nov 9;8(364):364ra155. doi: 10.1126/scitranslmed.aai8545.
10
Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
Int J Mol Sci. 2011;12(9):5684-97. doi: 10.3390/ijms12095684. Epub 2011 Sep 5.
Zotero 插件